Meeting Banner
Abstract #0896

MR spectroscopy of 2-hydroxyglutarate in patients with brainstem tumors in vivo

Changho Choi1, Vivek Tiwari1, Zhongxu An1, Sandeep Ganji2, Michael Levy1, Edward Pan1, Elizabeth Maher1, Toral Patel1, and Bruce Mickey1

1UT Southwestern Medical Center, Dallas, TX, United States, 2Philips Healthcare, Andover, MA, United States

MRS of 2-hydroxyglutarate (2HG) has the great potential for determining the isocitrate dehydrogenase (IDH) mutational status in brain tumors noninvasively. This clinical role of 2HG MRS may be demonstrated most clearly in patients with brainstem gliomas or deep brain lesions, where surgical biopsy presents significant risk of permanent neurological deficit. We report 2HG MRS data in patients with brainstem tumors. 2HG was evaluated, using a 2HG-optimized TE 97ms PRESS at 3T, in 12 subjects with brainstem lesions in vivo. We also presents data of monitoring the tumor with serial 2HG MRS scans.

This abstract and the presentation materials are available to members only; a login is required.

Join Here